Your browser doesn't support javascript.
loading
Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals.
McWhinney, Sean R; Brosch, Katharina; Calhoun, Vince D; Crespo-Facorro, Benedicto; Crossley, Nicolas A; Dannlowski, Udo; Dickie, Erin; Dietze, Lorielle M F; Donohoe, Gary; Du Plessis, Stefan; Ehrlich, Stefan; Emsley, Robin; Furstova, Petra; Glahn, David C; Gonzalez-Valderrama, Alfonso; Grotegerd, Dominik; Holleran, Laurena; Kircher, Tilo T J; Knytl, Pavel; Kolenic, Marian; Lencer, Rebekka; Nenadic, Igor; Opel, Nils; Pfarr, Julia-Katharina; Rodrigue, Amanda L; Rootes-Murdy, Kelly; Ross, Alex J; Sim, Kang; Skoch, Antonín; Spaniel, Filip; Stein, Frederike; Svancer, Patrik; Tordesillas-Gutiérrez, Diana; Undurraga, Juan; Vázquez-Bourgon, Javier; Voineskos, Aristotle; Walton, Esther; Weickert, Thomas W; Weickert, Cynthia Shannon; Thompson, Paul M; van Erp, Theo G M; Turner, Jessica A; Hajek, Tomas.
Afiliação
  • McWhinney SR; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Brosch K; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Calhoun VD; Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Emory University, Atlanta, GA, USA.
  • Crespo-Facorro B; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Crossley NA; IBiS, University Hospital Virgen del Rocio, Sevilla, Spain.
  • Dannlowski U; Department of Psychiatry, School of Medicine, University of Sevilla, Sevilla, Spain.
  • Dickie E; Department of Psychiatry, School of Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Dietze LMF; Department of Psychosis Studies, King's College London, London, UK.
  • Donohoe G; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Du Plessis S; Centre for Addiction & Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Ehrlich S; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Emsley R; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Furstova P; Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Glahn DC; SAMRC Genomics of Brain Disorders Unit, Cape Town, South Africa.
  • Gonzalez-Valderrama A; Translational Developmental Neuroscience Section, Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.
  • Grotegerd D; Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Holleran L; National Institute of Mental Health, Klecany, Czech Republic.
  • Kircher TTJ; Department of Psychiatry & Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA.
  • Knytl P; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Kolenic M; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.
  • Lencer R; School of Medicine, Universidad Finis Terrae, Santiago, Chile.
  • Nenadic I; Early Intervention in Psychosis Program, Instituto Psiquiátrico 'Dr. José Horwitz B.', Santiago, Chile.
  • Opel N; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Pfarr JK; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Rodrigue AL; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Rootes-Murdy K; National Institute of Mental Health, Klecany, Czech Republic.
  • Ross AJ; Charles University, Third Faculty of Medicine, Prague, Czech Republic.
  • Sim K; National Institute of Mental Health, Klecany, Czech Republic.
  • Skoch A; Charles University, Third Faculty of Medicine, Prague, Czech Republic.
  • Spaniel F; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Stein F; Department of Pscyhiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
  • Svancer P; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Tordesillas-Gutiérrez D; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Undurraga J; Department of Psychiatry, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.
  • Vázquez-Bourgon J; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Voineskos A; Department of Psychiatry & Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA.
  • Walton E; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Weickert TW; Department of Psychology, Georgia State University, Atlanta, GA, USA.
  • Weickert CS; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Thompson PM; West Region, Institute of Mental Health, Singapore, Singapore.
  • van Erp TGM; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Turner JA; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Hajek T; National Institute of Mental Health, Klecany, Czech Republic.
Mol Psychiatry ; 27(9): 3731-3737, 2022 09.
Article em En | MEDLINE | ID: mdl-35739320
ABSTRACT
Schizophrenia is frequently associated with obesity, which is linked with neurostructural alterations. Yet, we do not understand how the brain correlates of obesity map onto the brain changes in schizophrenia. We obtained MRI-derived brain cortical and subcortical measures and body mass index (BMI) from 1260 individuals with schizophrenia and 1761 controls from 12 independent research sites within the ENIGMA-Schizophrenia Working Group. We jointly modeled the statistical effects of schizophrenia and BMI using mixed effects. BMI was additively associated with structure of many of the same brain regions as schizophrenia, but the cortical and subcortical alterations in schizophrenia were more widespread and pronounced. Both BMI and schizophrenia were primarily associated with changes in cortical thickness, with fewer correlates in surface area. While, BMI was negatively associated with cortical thickness, the significant associations between BMI and surface area or subcortical volumes were positive. Lastly, the brain correlates of obesity were replicated among large studies and closely resembled neurostructural changes in major depressive disorders. We confirmed widespread associations between BMI and brain structure in individuals with schizophrenia. People with both obesity and schizophrenia showed more pronounced brain alterations than people with only one of these conditions. Obesity appears to be a relevant factor which could account for heterogeneity of brain imaging findings and for differences in brain imaging outcomes among people with schizophrenia.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá